Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis. [PDF]
CureusObjectives Tofacitinib, an effective Janus kinase inhibitor (JAKi), has gained increasing interest in recent years for the management of refractory alopecia areata (AA). One of the most prevalent autoimmune diseases is AA, a kind of non-scarring alopecia.
Tirmizi SS +3 more
europepmc +3 more sources
Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis [PDF]
Case Reports in Dermatology, 2013 Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site.
Hassan Riad +6 more
doaj +2 more sources
Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial [PDF]
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong +5 more
doaj +5 more sources
Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2022 Kartika Ruchiatan, Erda Avriyanti, Reti Hindritiani, Diah Puspitosari, Oki Suwarsa, Hendra Gunawan Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr.
Ruchiatan K +5 more
doaj +2 more sources
Hairless Gene Nonsense Mutations in Alopecia Universalis: A Case Report [PDF]
Iranian Journal of Public Health, 2021 Alopecia universalis (AU) congenital, known as generalized atrichia, is a severe form of autosomal recessive alopecia that results in complete hair loss of scalp and body. Mutations in the human hairless gene (HR) are associated with the phenotype of the
Hamed Heidary +4 more
doaj +2 more sources
Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment [PDF]
Przegląd Dermatologiczny, 2023 The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska +8 more
doaj +2 more sources
Association of Alopecia Universalis, Generalized Vitiligo, and Graves' Disease [PDF]
Journal of Research in Medical Sciences, 2005 We present a 21-years old woman with alopecia universalis, generalized vitiligo, and Graves' disease. She had had thyroidectomy in early childhood and was receiving replacement therapy with levothyroxine.
Z Shahmoradi +2 more
doaj +1 more source
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study [PDF]
Acta Dermato-Venereologica, 2018 Treatment of alopecia totalis and alopecia universalis is often challenging and unsatisfactory. Recently, Janus kinase inhibitor has shown promising results.
Jung-Won Shin +6 more
doaj +2 more sources
A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib [PDF]
JAAD Case Reports, 2022 Zhao J, Liu L.
exaly +2 more sources
Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222) [PDF]
JAAD Case Reports, 2022 Jonathan Ho
exaly +2 more sources